id crelsevierbv:10.1016/s2213-2600(19)30338-8
record_format openpolar
spelling crelsevierbv:10.1016/s2213-2600(19)30338-8 2024-05-19T07:49:23+00:00 Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies Criner, Gerard J Celli, Bartolome R Singh, Dave Agusti, Alvar Papi, Alberto Jison, Maria Makulova, Natalya Shih, Vivian H Brooks, Laura Barker, Peter Martin, Ubaldo J Newbold, Paul 2020 http://dx.doi.org/10.1016/s2213-2600(19)30338-8 https://api.elsevier.com/content/article/PII:S2213260019303388?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S2213260019303388?httpAccept=text/plain en eng Elsevier BV https://www.elsevier.com/tdm/userlicense/1.0/ The Lancet Respiratory Medicine volume 8, issue 2, page 158-170 ISSN 2213-2600 Pulmonary and Respiratory Medicine journal-article 2020 crelsevierbv https://doi.org/10.1016/s2213-2600(19)30338-8 2024-04-19T06:49:58Z Article in Journal/Newspaper Terranova ScienceDirect (Elsevier) The Lancet Respiratory Medicine 8 2 158 170
institution Open Polar
collection ScienceDirect (Elsevier)
op_collection_id crelsevierbv
language English
topic Pulmonary and Respiratory Medicine
spellingShingle Pulmonary and Respiratory Medicine
Criner, Gerard J
Celli, Bartolome R
Singh, Dave
Agusti, Alvar
Papi, Alberto
Jison, Maria
Makulova, Natalya
Shih, Vivian H
Brooks, Laura
Barker, Peter
Martin, Ubaldo J
Newbold, Paul
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
topic_facet Pulmonary and Respiratory Medicine
format Article in Journal/Newspaper
author Criner, Gerard J
Celli, Bartolome R
Singh, Dave
Agusti, Alvar
Papi, Alberto
Jison, Maria
Makulova, Natalya
Shih, Vivian H
Brooks, Laura
Barker, Peter
Martin, Ubaldo J
Newbold, Paul
author_facet Criner, Gerard J
Celli, Bartolome R
Singh, Dave
Agusti, Alvar
Papi, Alberto
Jison, Maria
Makulova, Natalya
Shih, Vivian H
Brooks, Laura
Barker, Peter
Martin, Ubaldo J
Newbold, Paul
author_sort Criner, Gerard J
title Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
title_short Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
title_full Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
title_fullStr Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
title_full_unstemmed Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
title_sort predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of galathea and terranova studies
publisher Elsevier BV
publishDate 2020
url http://dx.doi.org/10.1016/s2213-2600(19)30338-8
https://api.elsevier.com/content/article/PII:S2213260019303388?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2213260019303388?httpAccept=text/plain
genre Terranova
genre_facet Terranova
op_source The Lancet Respiratory Medicine
volume 8, issue 2, page 158-170
ISSN 2213-2600
op_rights https://www.elsevier.com/tdm/userlicense/1.0/
op_doi https://doi.org/10.1016/s2213-2600(19)30338-8
container_title The Lancet Respiratory Medicine
container_volume 8
container_issue 2
container_start_page 158
op_container_end_page 170
_version_ 1799467883300913152